Call: (513) 978-0980 info@innovativehci.com
Weekdays: 9am-5pm EST Saturday & Sunday: Closed

    • 2024 Precision Oncology Forum

    Saturday, March 2, 2024

    Presented by the Innovative Healthcare Institute and Journal of Immunotherapy and Precision Oncology

    Call for Abstracts

    Our Objectives

    To present the latest advances in the field of precision oncology especially in testing approaches.

    To discuss the application of
    these advances in patient care.

    To share real world experiences and case studies of integrating precision medicine into clinical practice.

    Submit an Abstract

    Target Audience

    All healthcare professionals with interest in cancer care from all specialties and disciplines including physicians, oncology nurse practitioners, physician assistant, genetic counselors, scientists, pharmacists, nurses, and other allied healthcare professionals.

    Register here

    Themes

    Venue

    The Precision Oncology Forum will be held at the Hyatt Regency in downtown Cincinnati, Ohio, the future hub for Global Healthcare Innovation. We will continue to work closely with the hotel for covid requirements, as the health and safety of our attendees, partners, exhibitors, speakers, and staff are of utmost importance to us.

    “Precision medicine is diving into the DNA with a knowledge that everybody's tumor has a unique genetic profile and you want to be able to identify that specific piece of DNA that has become mutated and that is driving cancer growth.”
    Laurie GlimcherPresident of the Dana–Farber Cancer Institute
    My goal is to improve cancer care across borders through capacity building, professional development and training, facilitating collaboration, adopting innovations, encouraging research, and enhancing evidence based, safe, and multidisciplinary care for cancer patients.
    ABDUL RAHMAN JAZIEH, MD, MPHDirector of Innovation & Research Cincinnati Cancer Advisors
    Trials are very important and crucial for the final goal of getting access of new drugs to our patients.
    Christian Rolfo, MD, PhD, MBAAssoc Director Clinical Research. Center for Thoracic Oncology.Tisch Cancer Institute
    • PO in cancer prevention, screening, and early detection
    • Available testing methods and their utilization in practice and challenges of testing
    • PO in lung cancer and other solid tumors
    • Rare cancers/mutations
    • Site-agnostic actionable targets
    • Role of PO in surveillance, disease monitoring and treatment termination decision
    • Case studies of real-world application of PO in practice.